Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront